Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.
Kwong FLA, Kristunas C, Davenport C, Deeks J, Mallett S, Agarwal R, Kehoe S, Timmerman D, Bourne T, Stobart H, Neal R, Menon U, Gentry-Maharaj A, Brenton J, Rosenfeld N, Sturdy L, Ottridge R, Sundar SS; ROCkeTS collaborators.
Kwong FLA, et al. Among authors: kehoe s.
Int J Gynecol Cancer. 2024 Sep 25:ijgc-2024-005371. doi: 10.1136/ijgc-2024-005371. Online ahead of print.
Int J Gynecol Cancer. 2024.
PMID: 39138005